ARCHIVES

Sanofi Responds to Criticism From Oncologists

This article is from The Cancer Letter archive.

Vol. 38 No. 42 | November 8, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014

FDA Approves Manufacturer Of IVAX Paclitaxel Ingredient.

June 29, 2001

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

BCF Members Miffed When NCI Refuses To Delay New Breast Cancer RFA To Allow Them Chance To Study It

April 8, 1983

LeMaistre Blasts “Death Merchants’ In tobacco Industry

May 5, 1989

NIH Funds 11 New Grants In Women’s Health Research.

September 29, 2000